Your browser doesn't support javascript.
loading
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
Bentley-Lewis, Rhonda; Aguilar, David; Riddle, Matthew C; Claggett, Brian; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C; Johnston, Peter; Køber, Lars V; Lawson, Francesca; Lewis, Eldrin F; Maggioni, Aldo P; McMurray, John J V; Ping, Lin; Probstfield, Jeffrey L; Solomon, Scott D; Tardif, Jean-Claude; Wu, Yujun; Pfeffer, Marc A.
Afiliação
  • Bentley-Lewis R; Department of Medicine/Diabetes Unit, Massachusetts General Hospital, Boston, MA. Electronic address: rbentleylewis@partners.org.
  • Aguilar D; Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Riddle MC; Department of Medicine, Oregon Health & Science University, Portland, OR.
  • Claggett B; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston MA.
  • Diaz R; Estudios Cardiologicos Latinoamerica, Rosario, Santa Fe, Argentina.
  • Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
  • Gerstein HC; Department of Medicine and Population Health Research Institute, McMaster University & Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Johnston P; Sanofi-Aventis, Bridgewater, NJ.
  • Køber LV; The Heart Centre, Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
  • Lawson F; Sanofi-Aventis, Bridgewater, NJ.
  • Lewis EF; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston MA.
  • Maggioni AP; ANMCO Research Center, Florence, Italy.
  • McMurray JJ; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Ping L; Sanofi-Aventis, Bridgewater, NJ.
  • Probstfield JL; Department of Medicine/Cardiology, University of Washington Medical Center, Seattle, WA.
  • Solomon SD; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston MA.
  • Tardif JC; Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada.
  • Wu Y; Sanofi-Aventis, Bridgewater, NJ.
  • Pfeffer MA; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston MA.
Am Heart J ; 169(5): 631-638.e7, 2015 May.
Article em En | MEDLINE | ID: mdl-25965710
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Quinases p38 Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Síndrome Coronariana Aguda Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Quinases p38 Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Síndrome Coronariana Aguda Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article